In contrast to AKR1B1, AKR1B10 expression was significantly decreased in gastric cancer and associated with tumor size, stage, and metastasis, suggesting that AKR1B10 may be a reliable prognostic indicator [108]. This evidence concerns the gene AKR1B10 and neoplasm.